CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA
Publication/Presentation Date
11-2020
Volume
22
Issue
2
Published In/Presented At
Grommes, C., Mehta, M., Miller, A., Daras, M., Piotrowski, A., Boire, A., Butler, B., Stone, J., Pentsova, E., Kotecha, R., Morrison, T., Odia, Y., Mellinghoff, I., & Beal, K. (2020). CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA. Neuro-Oncology, 22(Suppl 2), ii36. https://doi.org/10.1093/neuonc/noaa215.149
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine
Document Type
Article
COinS